Best Practices in Pharmaceutical Remote Audits During COVID-19 and Beyond

Introduction: This presentation will discuss the role that remote auditing has played in pharmaceutical quality during the coronavirus pandemic. It will discuss best practices, and observations from both the supplier and manufacturer point of view. The presentation will also cover the expected role that remote auditing will continue to play post COVID-19.

Time: 16:00~17:00 22 June (UTC+8)

Organizer: CPhI China

Co-organizer: Rx-360

Agenda

• Welcome and Introduction

• What is a Remote Audit?

• Why Conduct a Remote Audit?

• Best Practices

• What is Next in the Remote Audit Arena?

Speakers